STOCK TITAN

Itron Inc SEC Filings

ITRI NASDAQ

Welcome to our dedicated page for Itron SEC filings (Ticker: ITRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Itron Inc. filings document the reporting, governance and capital-structure records of an operating company serving utility and city infrastructure markets. Recent 8-K disclosures cover operating results, financial-condition updates, material agreements and the issuance of convertible senior notes, including purchase agreement and indenture terms tied to the company’s debt and equity structure.

Proxy and shareholder-vote filings describe director elections, advisory executive-compensation votes and annual meeting matters for holders of Itron common stock. Other material-event filings record cybersecurity response and operational-continuity disclosures, while exchange-registration information identifies ITRI common stock, no par value, as listed on the Nasdaq Global Select Market.

Rhea-AI Summary

Insider sale to cover tax withholding on RSU vesting. David Marshall Wright, VP, Corporate Controller & CAO of Itron, Inc. (ITRI), reported a disposition of 106 shares of Itron common stock on 08/25/2025 at a reported price of $125.3071 per share. After the transaction he beneficially owned 7,685 shares directly. The filing states the shares were "automatically sold to cover tax withholding obligations" associated with the vesting of a restricted stock unit award. The Form 4 was signed by an attorney-in-fact on 08/26/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Itron Inc. (ITRI) Form 144 notice reports a proposed sale of 110 common shares through Fidelity Brokerage Services with an aggregate market value of $13,783.78 and approximately 45,717,933 shares outstanding. The shares were acquired on 08/22/2025 through restricted stock vesting and paid as compensation. The filer, identified in the sale history as Laurie A. Hahn, sold 107 shares on 05/27/2025 for $12,299.13 and 78 shares on 08/11/2025 for $9,722.43. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Form 144 filed for Itron, Inc. (ITRI) reports a proposed sale of 106 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $13,282.56 and an approximate sale date of 08/25/2025 on NASDAQ. The 106 shares were acquired on 08/22/2025 via restricted stock vesting and were paid as compensation. The filer also reported a prior sale in the past three months of 102 shares on 05/27/2025 for gross proceeds of $11,724.40. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Summary of Form 144 for Itron, Inc. (ITRI)

This notice reports a proposed sale of 351 shares of ITRI common stock by an insider through Fidelity Brokerage Services on 08/25/2025 with an aggregate market value of $43,982.79. The shares were acquired via restricted stock vesting on 08/22/2025 and were issued as compensation. The filing shows 45,717,933 shares outstanding for the class. The filer sold 339 shares on 05/27/2025 for $38,966.39. The notice includes the standard insider representation that no undisclosed material adverse information is known.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Itron Inc (ITRI) reported a Form 144 notice for the proposed sale of 970 common shares, acquired through restricted stock vesting on 08/22/2025 as compensation. The shares are to be sold approximately on 08/25/2025 through Fidelity Brokerage Services LLC, with an aggregate market value reported as $121,547.88. The filing shows 45,717,933 shares outstanding, which places the planned sale at a very small fraction of the outstanding stock. The filer also disclosed a prior sale by Joan S. Hooper of 938 shares on 05/27/2025 generating $107,818.50 in gross proceeds.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Form 144 notice for proposed sale of Itron, Inc. (ITRI) securities. The filer reports an intended sale of 565 common shares through Fidelity Brokerage Services with an aggregate market value of $70,798.51 and an approximate sale date of 08/25/2025 on NASDAQ. The shares were acquired on 08/22/2025 by restricted stock vesting from the issuer and were received as compensation. The filing also discloses three prior sales by John Marcolini during May–June 2025 totaling 11,233 shares for gross proceeds of $1,328,377.61. The submission includes the required representation about public disclosure and trading-plan statements. Some standard filer/issuer identification fields are blank in the provided text.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Form 144 notice for proposed sale of 547 shares of common stock, to be effected through Fidelity Brokerage Services on NASDAQ on 08/25/2025 with an aggregate market value of $68,542.99. The filing shows these 547 shares were acquired on 08/22/2025 through restricted stock vesting from the issuer and were recorded as compensation paid on 08/22/2025. The filing also discloses a prior sale by Donald Reeves of 529 shares on 05/27/2025 for gross proceeds of $60,805.96. The form lists total shares outstanding as 45,717,933. Several identifying fields for the filer and issuer (CIK, issuer name and contact details) are blank in the provided content.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Form 144 notice for Itron, Inc. (ITRI) shows a proposed sale of 1,786 common shares held at Fidelity Brokerage Services with an aggregate market value of $223,798.48, with an approximate sale date of 08/25/2025 on NASDAQ. The shares were acquired on 08/22/2025 through restricted stock vesting and the payment nature is listed as compensation. The filing also discloses prior sales by the same person in the past three months: 1,729 shares sold on 05/27/2025 for $198,740.08 and 35,461 shares sold on 06/04/2025 for $4,245,142.69. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Itron Inc. (ITRI) Form 144 shows a proposed sale of 388 common shares through Fidelity Brokerage Services LLC on 08/25/2025 with an aggregate market value of $48,619.15. The shares were acquired on 08/22/2025 through restricted stock vesting from the issuer and were paid as compensation. The filing also discloses two prior sales by the same individual: 375 shares on 05/27/2025 for $43,104.41 and 9,036 shares on 06/10/2025 for $1,100,313.72. The filer certifies no undisclosed material adverse information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Itron, Inc. (ITRI) director Drury Scott D. filed an initial Form 3 reporting his insider status with the company. He is identified as a director and not as an officer or 10% owner. The filing states in the Explanation of Responses that no securities are beneficially owned, and both the non-derivative and derivative holdings tables are effectively empty. The form is filed as an individual reporting person, establishing his insider reporting obligations going forward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Itron (ITRI) SEC filings are available on StockTitan?

StockTitan tracks 174 SEC filings for Itron (ITRI), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Itron (ITRI)?

The most recent SEC filing for Itron (ITRI) was filed on August 26, 2025.